Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) EV/Sales
As of 5 November 2026, Doximity, Inc. (DOCS) trades at a EV/Sales of 7.9×. Over the past ten years it has ranged from 4.1× (May 2026) to 55.1× (October 2021); the current reading is higher than 17% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2026 | 5.6× | (67.84%) |
| FY2025 | 17.4× | 94.24% |
| FY2024 | 9.0× | (30.65%) |
| FY2023 | 12.9× | (42.49%) |
| FY2022 | 22.5× | 22.39% |
| FY2021 | 18.4× | 0.00% |
| FY2020 | 18.4× | 0.00% |
| FY2019 | 18.4× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 6.6× | 39.12% |
| Jun 2026 | 4.7× | (15.54%) |
| Mar 2026 | 5.6× | (52.83%) |
| Dec 2025 | 11.9× | (42.65%) |
| 23 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 1.0× |
| PRVA Privia Health Group, Inc. compare | 1.1× |
| WAY Waystar Holding Corp. compare | 5.3× |
| SDGR Schrodinger, Inc. compare | 6.7× |
| HQY HealthEquity, Inc. compare | 6.8× |
| DOCS Doximity, Inc. | 7.9× |
| TEM Tempus AI, Inc. compare | 8.9× |
| HNGE Hinge Health Inc. compare | 12.2× |
| HTFL Heartflow, Inc. compare | 21.4× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement